Company Overview of Editas Medicine, Inc.
Key Executives for Editas Medicine, Inc.
|Katrine S. Bosley||36 Relationships||Chief Executive Officer, President and Director||49|
|George M. Church Ph.D.||237 Relationships||Co-Founder and Scientific Advisory Board Member||63|
|Jennifer A. Doudna Ph.D.||41 Relationships||Co-Founder||--|
|J. Keith Joung M.D., Ph.D.||33 Relationships||Co-Founder and Scientific Advisory Board Member||--|
|David R. Liu Ph.D.||48 Relationships||Co-Founder and Scientific Advisory Board Member||--|
|View More Key Executives|
Editas Medicine, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Katrine S. Bosley||36 Relationships||Editas Medicine, Inc.||49|
|Feng Zhang Ph.D.||105 Relationships||Editas Medicine, Inc.||--|
|George M. Church Ph.D.||237 Relationships||Editas Medicine, Inc.||63|
|J. Keith Joung M.D., Ph.D.||33 Relationships||Editas Medicine, Inc.||--|
|David R. Liu Ph.D.||48 Relationships||Editas Medicine, Inc.||--|
Editas Medicine, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Andrew Hirsch||27 Relationships||3 Executives|
|Compensation Committee Ph.D., J.D.||John D. Mendlein||83 Relationships||3 Executives|
|Nominating Committee Ph.D., J.D.||John D. Mendlein||83 Relationships||3 Executives|
|Corporate Governance Committee Ph.D., J.D.||John D. Mendlein||83 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$450.0K|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.